Biosimilars are driving down drug costs, expanding access to critical treatments, and creating space for future innovation. In this episode, Linda Choi MacDonald, EVP and Global Head of Commercial at Samsung Bioepis, discusses the challenges slowing biosimilar development — and how policy reforms, stronger incentives, and provider education can help close the gap.

Read more: https://www.statnews.com/sponsor/2025/09/18/can-provider-education-and-smarter-policy-close-the-biosimilars-gap/